Epidemiology of Preventable Drug-Related Problems

Aim: Drug-related problems (DRPs) "are the unwanted effects of drugs that potentially lead to a harmful outcome" thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among chil...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Drug, healthcare and patient safety healthcare and patient safety, 2019-12, p.95
Hauptverfasser: Alazmi, Aeshah, Elzain, Rawan Mohammed, Algarni, Hanan, Al Shaikh, Adnan, Al Thubaiti, Rihad S, Aseeri, Mohammed, Ahmed, Omaima, Alhamdan, Hani
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 95
container_title Drug, healthcare and patient safety
container_volume
creator Alazmi, Aeshah
Elzain, Rawan Mohammed
Algarni, Hanan
Al Shaikh, Adnan
Al Thubaiti, Rihad S
Aseeri, Mohammed
Ahmed, Omaima
Alhamdan, Hani
description Aim: Drug-related problems (DRPs) "are the unwanted effects of drugs that potentially lead to a harmful outcome" thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods: A prospective observational study of children ([less than or equal to]15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results: A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age [less than or equal to]2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion: Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority. Keywords: children, risk factors, drug-related problems, hospitalized pediatric patients
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_healthsolutions_A611435714</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A611435714</galeid><sourcerecordid>A611435714</sourcerecordid><originalsourceid>FETCH-gale_healthsolutions_A6114357143</originalsourceid><addsrcrecordid>eNpjYuA0NDS31DU0NjNlQWJzMPAWF2cZAIGxpZGJhREng6FrQWZKam5mfk5-eqVCfppCQFFqWWpeSWJSTqqCS1Fpum5Qak5iSWoKUCIfKJZbzMPAmpaYU5zKC6W5GdTcXEOcPXTTE3NS4zNSE3NKMorzc0pLMvPziuMdzQwNTYxNzYEE0QoBSHE3kw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Epidemiology of Preventable Drug-Related Problems</title><source>Taylor &amp; Francis Open Access</source><source>DOVE Medical Press Journals</source><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Alazmi, Aeshah ; Elzain, Rawan Mohammed ; Algarni, Hanan ; Al Shaikh, Adnan ; Al Thubaiti, Rihad S ; Aseeri, Mohammed ; Ahmed, Omaima ; Alhamdan, Hani</creator><creatorcontrib>Alazmi, Aeshah ; Elzain, Rawan Mohammed ; Algarni, Hanan ; Al Shaikh, Adnan ; Al Thubaiti, Rihad S ; Aseeri, Mohammed ; Ahmed, Omaima ; Alhamdan, Hani</creatorcontrib><description>Aim: Drug-related problems (DRPs) "are the unwanted effects of drugs that potentially lead to a harmful outcome" thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods: A prospective observational study of children ([less than or equal to]15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results: A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age [less than or equal to]2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion: Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority. Keywords: children, risk factors, drug-related problems, hospitalized pediatric patients</description><identifier>ISSN: 1179-1365</identifier><identifier>EISSN: 1179-1365</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Child health ; Children ; Drugs ; Epidemiology ; Medical personnel ; Pediatrics</subject><ispartof>Drug, healthcare and patient safety, 2019-12, p.95</ispartof><rights>COPYRIGHT 2019 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids></links><search><creatorcontrib>Alazmi, Aeshah</creatorcontrib><creatorcontrib>Elzain, Rawan Mohammed</creatorcontrib><creatorcontrib>Algarni, Hanan</creatorcontrib><creatorcontrib>Al Shaikh, Adnan</creatorcontrib><creatorcontrib>Al Thubaiti, Rihad S</creatorcontrib><creatorcontrib>Aseeri, Mohammed</creatorcontrib><creatorcontrib>Ahmed, Omaima</creatorcontrib><creatorcontrib>Alhamdan, Hani</creatorcontrib><title>Epidemiology of Preventable Drug-Related Problems</title><title>Drug, healthcare and patient safety</title><description>Aim: Drug-related problems (DRPs) "are the unwanted effects of drugs that potentially lead to a harmful outcome" thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods: A prospective observational study of children ([less than or equal to]15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results: A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age [less than or equal to]2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion: Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority. Keywords: children, risk factors, drug-related problems, hospitalized pediatric patients</description><subject>Child health</subject><subject>Children</subject><subject>Drugs</subject><subject>Epidemiology</subject><subject>Medical personnel</subject><subject>Pediatrics</subject><issn>1179-1365</issn><issn>1179-1365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNpjYuA0NDS31DU0NjNlQWJzMPAWF2cZAIGxpZGJhREng6FrQWZKam5mfk5-eqVCfppCQFFqWWpeSWJSTqqCS1Fpum5Qak5iSWoKUCIfKJZbzMPAmpaYU5zKC6W5GdTcXEOcPXTTE3NS4zNSE3NKMorzc0pLMvPziuMdzQwNTYxNzYEE0QoBSHE3kw</recordid><startdate>20191201</startdate><enddate>20191201</enddate><creator>Alazmi, Aeshah</creator><creator>Elzain, Rawan Mohammed</creator><creator>Algarni, Hanan</creator><creator>Al Shaikh, Adnan</creator><creator>Al Thubaiti, Rihad S</creator><creator>Aseeri, Mohammed</creator><creator>Ahmed, Omaima</creator><creator>Alhamdan, Hani</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20191201</creationdate><title>Epidemiology of Preventable Drug-Related Problems</title><author>Alazmi, Aeshah ; Elzain, Rawan Mohammed ; Algarni, Hanan ; Al Shaikh, Adnan ; Al Thubaiti, Rihad S ; Aseeri, Mohammed ; Ahmed, Omaima ; Alhamdan, Hani</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-gale_healthsolutions_A6114357143</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Child health</topic><topic>Children</topic><topic>Drugs</topic><topic>Epidemiology</topic><topic>Medical personnel</topic><topic>Pediatrics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alazmi, Aeshah</creatorcontrib><creatorcontrib>Elzain, Rawan Mohammed</creatorcontrib><creatorcontrib>Algarni, Hanan</creatorcontrib><creatorcontrib>Al Shaikh, Adnan</creatorcontrib><creatorcontrib>Al Thubaiti, Rihad S</creatorcontrib><creatorcontrib>Aseeri, Mohammed</creatorcontrib><creatorcontrib>Ahmed, Omaima</creatorcontrib><creatorcontrib>Alhamdan, Hani</creatorcontrib><jtitle>Drug, healthcare and patient safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alazmi, Aeshah</au><au>Elzain, Rawan Mohammed</au><au>Algarni, Hanan</au><au>Al Shaikh, Adnan</au><au>Al Thubaiti, Rihad S</au><au>Aseeri, Mohammed</au><au>Ahmed, Omaima</au><au>Alhamdan, Hani</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Epidemiology of Preventable Drug-Related Problems</atitle><jtitle>Drug, healthcare and patient safety</jtitle><date>2019-12-01</date><risdate>2019</risdate><spage>95</spage><pages>95-</pages><issn>1179-1365</issn><eissn>1179-1365</eissn><abstract>Aim: Drug-related problems (DRPs) "are the unwanted effects of drugs that potentially lead to a harmful outcome" thereby requiring considerable attention. Hospitalized pediatric patients, in particular, represent a population at risk of DRPs. The epidemiology of preventable DRPs among children in Saudi Arabia remains scarce, which thus poses distinct challenges to all healthcare professionals. We aim to characterize preventable DRPs among hospitalized children at KAMC-Jeddah. Methods: A prospective observational study of children ([less than or equal to]15 years) admitted to pediatric units (excluding cancer units) at KAMC-Jeddah over a 3-month period (May 29 to August 30, 2016) is carried out to determine the incidence of preventable DRPs and investigate the possible associated factors (gender, age, admission location, type of admission, and number of medications). Results: A total of 319 DRPs were identified among 235 patients, of which 280 DRPs (87.8%, 280/319) were deemed preventable. The majority of preventable DRPs were related to dose selection (78%, 219/280). None of the preventable DRPs were life threatening or fatal, and the majority were assessed as moderate in severity (94.3%, 264/280). There was no significant difference between DRP incidences with age mean 3.5 (P=0.389), gender mean (P=0.436), and weight mean 13.47 (P=0.323). Younger children (age [less than or equal to]2years) admitted to PICU were more likely to have DRP (OR 4.44, 95% CI, 1.87 to 10.52, P=0.00001). Scheduled admissions were 2.89 times more likely to be exposed to DRP compared to transferred admissions (OR 2.8, 95% CI, 1.83 to 4.70, P=0.005). Additionally, DRP incidences increased proportionally to the number of medications. Conclusion: Our data suggest that establishing appropriate prevention strategies towards improvement and safety in medicine use among this vulnerable patient population is a high priority. Keywords: children, risk factors, drug-related problems, hospitalized pediatric patients</abstract><pub>Dove Medical Press Limited</pub></addata></record>
fulltext fulltext
identifier ISSN: 1179-1365
ispartof Drug, healthcare and patient safety, 2019-12, p.95
issn 1179-1365
1179-1365
language eng
recordid cdi_gale_healthsolutions_A611435714
source Taylor & Francis Open Access; DOVE Medical Press Journals; DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Child health
Children
Drugs
Epidemiology
Medical personnel
Pediatrics
title Epidemiology of Preventable Drug-Related Problems
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T13%3A28%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Epidemiology%20of%20Preventable%20Drug-Related%20Problems&rft.jtitle=Drug,%20healthcare%20and%20patient%20safety&rft.au=Alazmi,%20Aeshah&rft.date=2019-12-01&rft.spage=95&rft.pages=95-&rft.issn=1179-1365&rft.eissn=1179-1365&rft_id=info:doi/&rft_dat=%3Cgale%3EA611435714%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A611435714&rfr_iscdi=true